141 related articles for article (PubMed ID: 9475511)
1. Increases in fragmented glial fibrillary acidic protein levels in the spinal cords of patients with amyotrophic lateral sclerosis.
Fujita K; Kato T; Yamauchi M; Ando M; Honda M; Nagata Y
Neurochem Res; 1998 Feb; 23(2):169-74. PubMed ID: 9475511
[TBL] [Abstract][Full Text] [Related]
2. Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouse.
Fujita K; Yamauchi M; Matsui T; Titani K; Takahashi H; Kato T; Isomura G; Ando M; Nagata Y
Brain Res; 1998 Feb; 785(1):31-40. PubMed ID: 9526038
[TBL] [Abstract][Full Text] [Related]
3. Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells.
Keller AF; Gravel M; Kriz J
Glia; 2009 Aug; 57(10):1130-42. PubMed ID: 19115383
[TBL] [Abstract][Full Text] [Related]
4. Increased phospho-adducin immunoreactivity in a murine model of amyotrophic lateral sclerosis.
Shan X; Hu JH; Cayabyab FS; Krieger C
Neuroscience; 2005; 134(3):833-46. PubMed ID: 15994023
[TBL] [Abstract][Full Text] [Related]
5. Oxidative damage to proteins in the spinal cord in amyotrophic lateral sclerosis (ALS).
Niebrój-Dobosz I; Dziewulska D; Kwieciński H
Folia Neuropathol; 2004; 42(3):151-6. PubMed ID: 15535033
[TBL] [Abstract][Full Text] [Related]
6. (-)-Deprenyl alleviates the degenerative changes induced in the neonatal rat spinal cord by CSF from amyotrophic lateral sclerosis patients.
Shahani N; Gourie-Devi M; Nalini A; Rammohan P; Shobha K; Harsha HN; Raju TR
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):172-9. PubMed ID: 15512906
[TBL] [Abstract][Full Text] [Related]
7. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
Wootz H; Weber E; Korhonen L; Lindholm D
Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
[TBL] [Abstract][Full Text] [Related]
8. Reactive astrogliosis in neonatal rat spinal cord after exposure to cerebrospinal fluid from patients with amyotrophic lateral sclerosis.
Shahani N; Nalini A; Gourie-Devi M; Raju TR
Exp Neurol; 1998 Jan; 149(1):295-8. PubMed ID: 9454639
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide attenuates the degenerative changes induced by CSF from patients with amyotrophic lateral sclerosis in the neonatal rat spinal cord.
Shahani N; Gourie-Devi M; Nalini A; Raju TR
J Neurol Sci; 2001 Apr; 185(2):109-18. PubMed ID: 11311291
[TBL] [Abstract][Full Text] [Related]
10. Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1.
Warita H; Manabe Y; Murakami T; Shiote M; Shiro Y; Hayashi T; Nagano I; Shoji M; Abe K
Neurol Res; 2002 Sep; 24(6):577-81. PubMed ID: 12238624
[TBL] [Abstract][Full Text] [Related]
11. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
[TBL] [Abstract][Full Text] [Related]
12. Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Benninger F; Glat MJ; Offen D; Steiner I
J Clin Neurosci; 2016 Apr; 26():75-8. PubMed ID: 26602604
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of insulin-like growth factor-II receptor in reactive astrocytes in the spinal cord of amyotrophic lateral sclerosis transgenic rats.
Dagvajantsan B; Aoki M; Warita H; Suzuki N; Itoyama Y
Tohoku J Exp Med; 2008 Apr; 214(4):303-10. PubMed ID: 18441505
[TBL] [Abstract][Full Text] [Related]
14. iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis.
Sasaki S; Shibata N; Komori T; Iwata M
Neurosci Lett; 2000 Sep; 291(1):44-8. PubMed ID: 10962150
[TBL] [Abstract][Full Text] [Related]
15. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.
Bendotti C; Tortarolo M; Suchak SK; Calvaresi N; Carvelli L; Bastone A; Rizzi M; Rattray M; Mennini T
J Neurochem; 2001 Nov; 79(4):737-46. PubMed ID: 11723166
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays.
Malaspina A; Kaushik N; de Belleroche J
J Neurochem; 2001 Apr; 77(1):132-45. PubMed ID: 11279269
[TBL] [Abstract][Full Text] [Related]
17. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
[TBL] [Abstract][Full Text] [Related]
18. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.
Rothstein JD; Van Kammen M; Levey AI; Martin LJ; Kuncl RW
Ann Neurol; 1995 Jul; 38(1):73-84. PubMed ID: 7611729
[TBL] [Abstract][Full Text] [Related]
19. Increased Expression of 15-Hydroxyprostaglandin Dehydrogenase in Spinal Astrocytes During Disease Progression in a Model of Amyotrophic Lateral Sclerosis.
Miyagishi H; Kosuge Y; Takano A; Endo M; Nango H; Yamagata-Murayama S; Hirose D; Kano R; Tanaka Y; Ishige K; Ito Y
Cell Mol Neurobiol; 2017 Apr; 37(3):445-452. PubMed ID: 27140190
[TBL] [Abstract][Full Text] [Related]
20. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice.
Chen Y; Guan Y; Zhang Z; Liu H; Wang S; Yu L; Wu X; Wang X
Neurol Res; 2012 May; 34(4):390-9. PubMed ID: 22643084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
